Challenging Pharma towards Patient Centered Studies

Pharma effectively trains a "Challenger" Salesforce, as described in Harvard Business Review. We recently met with Dr. Molony to discuss the development of a short lunch lecture series at UT-Houston which would better prepare medical students to deal with this type of salesforce. In the long run, pharma will deliver only the evidence that doctors demand. As we begin to demand patient centered studies, leading Pharmas will react by funding more appropriate studies. Then, patient centered evidence becomes a competitive advantage.